As of Sep 01
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 3.00, with a high estimate of 9.00 and a low estimate of 2.70. The median estimate represents a +9.09% increase from the last price of 2.75.
The current consensus among 4 polled investment analysts is to Hold stock in Accretive Health Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.